Advancing Innovation in Oncology

From identifying key biomarkers to a diverse pipeline of investigational therapies, we aspire to lead advancements in cancer care.

From identifying key biomarkers to a diverse pipeline of investigational therapies, we aspire to lead advancements in cancer care.

Find currently enrolling clinical trials

Find out more about which tumor types are being studied in currently enrolling late-stage clinical trials.

Learn more about some of the immune signals and pathways tumors exploit to avoid an immune response.

Discover a broad range of development platforms such as small molecules and bispecific antibodies.